• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multicenter evaluation of arsenic trioxide dosing in obese patients with low-intermediate risk acute promyelocytic leukemia.

作者信息

Hickey Erin, Clemons Bryant, Griffin Shawn, Cox Jessica, Sutphin Stephanie, Ramlal Reshma, Benitez Lydia

机构信息

Department of Pharmacy, University of Kentucky HealthCare, Lexington, KY, USA.

Department of Pharmacy, Indiana University Health, Indianapolis, IN, USA.

出版信息

Leuk Lymphoma. 2019 Dec;60(14):3557-3560. doi: 10.1080/10428194.2019.1639163. Epub 2019 Jul 11.

DOI:10.1080/10428194.2019.1639163
PMID:31294640
Abstract
摘要

相似文献

1
Multicenter evaluation of arsenic trioxide dosing in obese patients with low-intermediate risk acute promyelocytic leukemia.低中危急性早幼粒细胞白血病肥胖患者三氧化二砷给药的多中心评估
Leuk Lymphoma. 2019 Dec;60(14):3557-3560. doi: 10.1080/10428194.2019.1639163. Epub 2019 Jul 11.
2
Effect of renal impairment on arsenic accumulation, methylation capacity, and safety in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.肾功能损害对三氧化二砷治疗急性早幼粒细胞白血病（APL）患者砷蓄积、甲基化能力和安全性的影响。
Expert Rev Clin Pharmacol. 2021 Sep;14(9):1173-1182. doi: 10.1080/17512433.2021.1938549. Epub 2021 Jun 28.
3
Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.口服与静脉用砷剂治疗急性早幼粒细胞白血病的疗效和不良反应：一项随机对照研究的荟萃分析。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820937008. doi: 10.1177/1533033820937008.
4
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia.三氧化二砷治疗急性早幼粒细胞白血病患者时出现的QT间期延长和室性心动过速。
Ann Intern Med. 2000 Dec 5;133(11):881-5. doi: 10.7326/0003-4819-133-11-200012050-00012.
5
Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.新型砷剂连续输注治疗初治急性早幼粒细胞白血病的临床药代动力学和安全性研究
Cancer Chemother Pharmacol. 2018 Aug;82(2):229-236. doi: 10.1007/s00280-018-3606-8. Epub 2018 May 29.
6
The simpler, the better: oral arsenic for acute promyelocytic leukemia.越简单越好：口服砷剂治疗急性早幼粒细胞白血病。
Blood. 2019 Aug 15;134(7):597-605. doi: 10.1182/blood.2019000760. Epub 2019 May 21.
7
Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.静脉注射三氧化二砷和全反式维甲酸作为低危急性早幼粒细胞白血病的一线治疗。
Expert Rev Hematol. 2019 Feb;12(2):81-87. doi: 10.1080/17474086.2019.1562332. Epub 2019 Jan 7.
8
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis.接受或未接受三氧化二砷治疗的成人急性早幼粒细胞白血病患者的二次癌症：一项监测、流行病学和最终结果计划（SEER）-医疗保险分析
Leukemia. 2020 Nov;34(11):3082-3084. doi: 10.1038/s41375-020-0905-y. Epub 2020 Jun 9.
9
Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.三氧化二砷与全反式维甲酸（ATRA）治疗所有风险组急性早幼粒细胞白血病：一项随机对照试验的研究方案
Trials. 2018 Sep 5;19(1):476. doi: 10.1186/s13063-018-2812-3.
10
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).在接受三氧化二砷治疗的老年新诊断标准风险急性早幼粒细胞白血病患者中降低死亡率需要大幅减少化疗：法国-比利时-瑞士急性早幼粒细胞白血病研究组报告（APL 2006试验）
Haematologica. 2018 Nov;103(11):e519-e521. doi: 10.3324/haematol.2018.193151. Epub 2018 May 24.

引用本文的文献

1
Management of acute promyelocytic leukemia in the setting of acute COVID-19 infection.急性新冠病毒感染背景下急性早幼粒细胞白血病的管理
Leuk Res Rep. 2022 Oct 19;18:100353. doi: 10.1016/j.lrr.2022.100353. eCollection 2022.
2
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.三氧化二砷剂量封顶以降低急性早幼粒细胞白血病治疗中的毒性。
J Oncol Pharm Pract. 2022 Sep;28(6):1340-1349. doi: 10.1177/10781552211024727. Epub 2021 Jun 17.
3
Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
砷中毒在急性早幼粒细胞白血病诱导治疗期间表现为大量水样腹泻。
Clin Case Rep. 2021 May 15;9(5):e04115. doi: 10.1002/ccr3.4115. eCollection 2021 May.
4
Old dog, new trick: Trivalent arsenic as an immunomodulatory drug.老药新用：三价砷作为免疫调节药物。
Br J Pharmacol. 2020 May;177(10):2199-2214. doi: 10.1111/bph.15011. Epub 2020 Mar 12.